IE
GSK icon

Israel Englander’s GSK GSK Stock Holding History

Israel Englander’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
207,500
+15,600
+8% +$825K ﹤0.01% 2201
2026
Q1 		$10.6M Buy
+191,900
New +$10.4M ﹤0.01% 2118
2025
Q3 		– Sell
-473,100
Closed -$18.2M – 6189
2025
Q2 		$18.2M Buy
473,100
+122,600
+35% +$4.68M 0.01% 1674
2025
Q1 		$13.6M Buy
350,500
+288,800
+468% +$10.6M 0.01% 1886
2024
Q4 		$2.09M Sell
61,700
-546,400
-90% -$19.7M ﹤0.01% 3612
2024
Q3 		$24.9M Sell
608,100
-143,000
-19% -$5.85M 0.01% 1353
2024
Q2 		$28.9M Buy
751,100
+590,000
+366% +$24.8M 0.01% 1182
2024
Q1 		$6.91M Buy
161,100
+124,400
+339% +$5.13M ﹤0.01% 2535
2023
Q4 		$1.36M Buy
36,700
+3,400
+10% +$122K ﹤0.01% 3921
2023
Q3 		$1.21M Buy
+33,300
New +$1.18M ﹤0.01% 4033
2023
Q2 		– Sell
-30,000
Closed -$1.07M – 6336
2023
Q1 		$1.07M Buy
+30,000
New +$1.05M ﹤0.01% 4031
2022
Q2 		– Sell
-400,000
Closed -$21.8M – 7170
2022
Q1 		$21.8M Buy
+400,000
New +$21.7M 0.01% 1308
2021
Q2 		– Sell
-40,000
Closed -$1.78M – 6733
2021
Q1 		$1.78M Buy
+40,000
New +$1.82M ﹤0.01% 3644
2020
Q3 		– Sell
-5,600
Closed -$286K – 4595
2020
Q2 		$286K Hold
5,600
– – ﹤0.01% 3681
2020
Q1 		$265K Sell
5,600
-24,000
-81% -$1.28M ﹤0.01% 3248
2019
Q4 		$1.74M Buy
+29,600
New +$1.65M ﹤0.01% 2699
2014
Q3 		– Sell
-5,600
Closed -$374K – 3804
2014
Q2 		$374K Buy
+5,600
New +$379K ﹤0.01% 2754
2013
Q4 		– Sell
-102,400
Closed -$6.42M – 3563
2013
Q3 		$6.42M Buy
+102,400
New +$6.59M 0.02% 968

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Israel Englander's GSK Position: Q2 2026 in Review

Israel Englander sold out of GSK (GSK) in Q2 2026, closing a stake of 4,067 shares — an estimated $215K sold.

Israel Englander first reported a position in GSK in Q3 2013 and held it in 49 quarters. The position peaked at $156M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Israel Englander reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 4,067 GSK shares in Q2 2026, an estimated $215K.
  • Israel Englander first reported a position in GSK in Q3 2013 and held it in 49 quarters.
  • Israel Englander's GSK position peaked at $156M in Q4 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.